Higher price of Covaxin in private markets needed to sustain costs: Bharat Biotech

Supply to the government of India at ₹150 per dose is a non-competitive price and clearly not sustainable in the long run, the company said

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Karnataka: BJP MLA used HIV positive women to honey trap rivals, probe launched

MUDA case: Karnataka HC rejects Siddaramaiah’s plea against Governor move